UK Indapamide Market Growth, Trends, Industry Analysis and Forecast - 2025

UK indapamide market is estimated to grow significantly at a CAGR of around 2.4% during the forecast period. A significant prevalence of CVDs has been witnessed in the country. According to the British Heart Foundation, more than one-fourth of the fatalities in UK occur due to CVDs, and it is responsible for around 1.6 million fatalities each year. Moreover, more than 7 million people live with one or the other type of heart diseases in UK in 2018. The rise in the aging population is increasing the prevalence rate of CVDs including stroke and other heart diseases. As per the Institute for Health Metrics and Evaluation, around 107,000 new cases of stroke were registered in the country in 2017. According to NHS, the cost incurred to the patients for the treatment of stroke is around $3.8 billion each year and a loss of $5.1 billion due to loss of productivity, disability, and informal care. Therefore, the increasing burden of stroke further raises the demand for indapamide for the preventive treatment in the country that further propels the market growth.

Get Sample Copy of UK Indapamide Market at: https://www.omrglobal.com/request-sample/uk-indapamide-market

The companies which are contributing to the growth of the UK indapamide market include Merck KGaA, Sanofi S.A., Mylan N.V., Laboratori Baldacci S.p.A., Sandoz International GmbH, Bioindustria L.I.M. S.p.A. and others.

The UK indapamide market is segmented on the basis of product and application. Based on product, the market is bifurcated into 1.25 mg and 2.5 mg. Among these, the market for 1.25 mg medicine held the significant market share owing to the extensive application of the drug in treating high blood pressure or hypertension. Based on the application, the market is segmented into high blood pressure, heart failure, and others. The high blood pressure segment is projected to have significant share in the market.

For More Information, get A full report of UK Indapamide Market is available at: https://www.omrglobal.com/industry-reports/uk-indapamide-market

Growing incidence of hypertension is contributing to market growth as indapamide drugs are significantly used to treat hypertension while reducing the risk of developing serious heart conditions. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.

Market Segmentation

UK Indapamide Market by Product

1.25 MG
2.5 MG

UK Indapamide Market by Application

High Blood Pressure
Heart Failure
Others

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/uk-indapamide-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.